Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corinne E Fischer

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
JAMA Psychiatry|October 30, 2024
Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment: A Randomized Clinical TrialTarek K Rajji, Christopher R Bowie, Nathan Herrmann, et al.
International Journal of Geriatric Psychiatry|April 17, 2025
A Cross Sectional and Longitudinal Assessment of Neuropsychiatric Symptoms and Brain Functional Connectivity in Patients With Mild Cognitive Impairment, Cerebrovascular Disease and Parkinson DiseaseNeda Rashidi-Ranjbar, Nathan W Churchill, Sandra E Black, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsDylan X Guan, Byron Creese, Cassandra M Germain, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 9, 2026
Validated Measures of Agitation in Neurocognitive Disorders: A Systematic Review of 41 Scales and Their Alignment With International Psychogeriatric Association CriteriaDylan X Guan, Amir AlSamsam, Arun Chinna-Meyyappan, et al.
Journal of Alzheimer'S Disease : JAD|March 3, 2020
Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 YearsArunima Kapoor, Robert Bartha, Sandra E Black, et al.
Journal of Alzheimer'S Disease : JAD|November 24, 2025
Plasma biomarkers in neuropsychiatric syndromes: A narrative reviewZahinoor Ismail, Dylan X Guan, Ganesh M Babulal, et al.
Alzheimer'S Research & Therapy|December 12, 2018
Correction to: The Toronto cognitive assessment (TorCA): normative data and validation to detect amnestic mild cognitive impairmentMorris Freedman, Larry Leach, M Carmela Tartaglia, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 5, 2023
Perivascular spaces mediate a relationship between diabetes and other cerebral small vessel disease markers in cerebrovascular and neurodegenerative diseasesJulia Zebarth, Radia Kamal, George Perlman, et al.
Alzheimer'S Research & Therapy|July 20, 2018
The Toronto Cognitive Assessment (TorCA): normative data and validation to detect amnestic mild cognitive impairmentMorris Freedman, Larry Leach, M Carmela Tartaglia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 19, 2024
Homocysteine, neurodegenerative biomarkers, and APOE ε4 in neurodegenerative diseasesWilliam Z Lin, Di Yu, Lisa Y Xiong, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
JAMA Psychiatry|October 30, 2024
Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment: A Randomized Clinical TrialTarek K Rajji, Christopher R Bowie, Nathan Herrmann, et al.
International Journal of Geriatric Psychiatry|April 17, 2025
A Cross Sectional and Longitudinal Assessment of Neuropsychiatric Symptoms and Brain Functional Connectivity in Patients With Mild Cognitive Impairment, Cerebrovascular Disease and Parkinson DiseaseNeda Rashidi-Ranjbar, Nathan W Churchill, Sandra E Black, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsDylan X Guan, Byron Creese, Cassandra M Germain, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 9, 2026
Validated Measures of Agitation in Neurocognitive Disorders: A Systematic Review of 41 Scales and Their Alignment With International Psychogeriatric Association CriteriaDylan X Guan, Amir AlSamsam, Arun Chinna-Meyyappan, et al.
Journal of Alzheimer'S Disease : JAD|March 3, 2020
Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 YearsArunima Kapoor, Robert Bartha, Sandra E Black, et al.
Journal of Alzheimer'S Disease : JAD|November 24, 2025
Plasma biomarkers in neuropsychiatric syndromes: A narrative reviewZahinoor Ismail, Dylan X Guan, Ganesh M Babulal, et al.
Alzheimer'S Research & Therapy|December 12, 2018
Correction to: The Toronto cognitive assessment (TorCA): normative data and validation to detect amnestic mild cognitive impairmentMorris Freedman, Larry Leach, M Carmela Tartaglia, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 5, 2023
Perivascular spaces mediate a relationship between diabetes and other cerebral small vessel disease markers in cerebrovascular and neurodegenerative diseasesJulia Zebarth, Radia Kamal, George Perlman, et al.
Alzheimer'S Research & Therapy|July 20, 2018
The Toronto Cognitive Assessment (TorCA): normative data and validation to detect amnestic mild cognitive impairmentMorris Freedman, Larry Leach, M Carmela Tartaglia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 19, 2024
Homocysteine, neurodegenerative biomarkers, and APOE ε4 in neurodegenerative diseasesWilliam Z Lin, Di Yu, Lisa Y Xiong, et al.
Pageof 16